1. TAM family kinases as therapeutic targets at the interface of cancer and immunity
   Deborah DeRyckere et al, 2023, Nature Reviews Clinical Oncology CrossRef
2. Development of Gilteritinib-Based Chimeric Small Molecules that Potently Induce Degradation of FLT3-ITD Protein
   Nobumichi Ohoka et al, 2022, ACS Medicinal Chemistry Letters CrossRef
3. A Receptor Tyrosine Kinase Inhibitor Sensitivity Prediction Model Identifies AXL Dependency in Leukemia
   Ahmad Nasimian et al, 2023, International Journal of Molecular Sciences CrossRef
4. Overcoming Resistance: FLT3 Inhibitors Past, Present, Future and the Challenge of Cure
   Debora Capelli et al, 2022, Cancers CrossRef